Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents
Michael Doulberis, Stergios A. Pοlyzos, Apostolis Papaefthymiou, et al.
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 3, pp. 247-251
Open Access | Times Cited: 10

Showing 10 citing articles:

Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Michael Doulberis, Simone Srivastava, Stergios A. Pοlyzos, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 933-933
Open Access | Times Cited: 67
Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
Yanyan Wang, Yunling Tai, Derrick Zhao, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 210-210
Open Access | Times Cited: 47
Helicobacter pylori Infection and Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Keyvan Heydari, Mohammad Yousefi, Reza Alizadeh‐Navaei, et al.
The Turkish Journal of Gastroenterology (2022) Vol. 33, Iss. 3, pp. 171-181
Open Access | Times Cited: 18
Non-alcoholic Fatty Liver Disease in Children
Emir Muzurović, Stergios A. Pοlyzos, Dimitri P. Mikhailidis, et al.
Current Vascular Pharmacology (2022) Vol. 21, Iss. 1, pp. 4-25
Closed Access | Times Cited: 15
Helicobacter pylori infection as a potential risk factor for multiple sclerosis
Jannis Kountouras, Apostolis Papaefthymiou, Emmanuel Gavalas, et al.
Medical Hypotheses (2020) Vol. 143, pp. 110135-110135
Closed Access | Times Cited: 16
Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients
Michael Doulberis, Noah Thierry Pierre, Giulia Manzini, et al.
Microorganisms (2021) Vol. 9, Iss. 7, pp. 1361-1361
Open Access | Times Cited: 12
Update on the association between non‐alcoholic fatty liver disease andHelicobacter pyloriinfection
Michael Doulberis, Apostolis Papaefthymiou, David Srivastava, et al.
International Journal of Clinical Practice (2020) Vol. 75, Iss. 4
Closed Access | Times Cited: 8
Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease
Apostolis Papaefthymiou, Michael Doulberis, Kyriaki Karafyllidou, et al.
Minerva Endocrinology (2021) Vol. 48, Iss. 3
Closed Access | Times Cited: 5
СУЧАСНІ КРИТЕРІЇ ВЕРІФІКАЦІЇ ТА ОСНОВНІ ПРИНЦИПИ ВЕДЕННЯ НЕАЛКОГОЛЬНОЇ ЖИРОВОЇ ХВОРОБИ ПЕЧІНКИ У ДІТЕЙ
О.А. Пода
The Medical and Ecological Problems (2021) Vol. 25, Iss. 1-2, pp. 50-56
Open Access | Times Cited: 1
Comorbidity of endocrine disorders in children with chronic liver disease visiting Children’s hospital of Tabriz University of Medical Sciences
Lida Saboktakin
Journal of Renal Endocrinology (2022) Vol. 8, pp. e17067-e17067
Open Access
Page 1

Scroll to top